BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 24456850)

  • 1. Corticotropin releasing factor: a key role in the neurobiology of addiction.
    Zorrilla EP; Logrip ML; Koob GF
    Front Neuroendocrinol; 2014 Apr; 35(2):234-44. PubMed ID: 24456850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Don't stress about CRF: assessing the translational failures of CRF
    Spierling SR; Zorrilla EP
    Psychopharmacology (Berl); 2017 May; 234(9-10):1467-1481. PubMed ID: 28265716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocircuitry of alcohol addiction: synthesis from animal models.
    Koob GF
    Handb Clin Neurol; 2014; 125():33-54. PubMed ID: 25307567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addiction as a stress surfeit disorder.
    Koob GF; Buck CL; Cohen A; Edwards S; Park PE; Schlosburg JE; Schmeichel B; Vendruscolo LF; Wade CL; Whitfield TW; George O
    Neuropharmacology; 2014 Jan; 76 Pt B(0 0):370-82. PubMed ID: 23747571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of CRF and CRF-related peptides in the dark side of addiction.
    Koob GF
    Brain Res; 2010 Feb; 1314():3-14. PubMed ID: 19912996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin-Releasing Factor (CRF) and Addictive Behaviors.
    Roberto M; Spierling SR; Kirson D; Zorrilla EP
    Int Rev Neurobiol; 2017; 136():5-51. PubMed ID: 29056155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism.
    Lowery EG; Thiele TE
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):77-86. PubMed ID: 20201818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization.
    Huang MM; Overstreet DH; Knapp DJ; Angel R; Wills TA; Navarro M; Rivier J; Vale W; Breese GR
    J Pharmacol Exp Ther; 2010 Jan; 332(1):298-307. PubMed ID: 19843974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder.
    Koob GF
    Curr Top Behav Neurosci; 2013; 13():3-30. PubMed ID: 21744309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction.
    Koob GF
    Psychopharmacology (Berl); 2017 May; 234(9-10):1315-1332. PubMed ID: 28050629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A key role for corticotropin-releasing factor in alcohol dependence.
    Heilig M; Koob GF
    Trends Neurosci; 2007 Aug; 30(8):399-406. PubMed ID: 17629579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats.
    Funk CK; O'Dell LE; Crawford EF; Koob GF
    J Neurosci; 2006 Nov; 26(44):11324-32. PubMed ID: 17079660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early life stress is a risk factor for excessive alcohol drinking and impulsivity in adults and is mediated via a CRF/GABA(A) mechanism.
    Gondré-Lewis MC; Warnock KT; Wang H; June HL; Bell KA; Rabe H; Tiruveedhula VV; Cook J; Lüddens H; Aurelian L; June HL
    Stress; 2016; 19(2):235-47. PubMed ID: 27023221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review. Neurobiological mechanisms for opponent motivational processes in addiction.
    Koob GF; Le Moal M
    Philos Trans R Soc Lond B Biol Sci; 2008 Oct; 363(1507):3113-23. PubMed ID: 18653439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurobiological substrates for the dark side of compulsivity in addiction.
    Koob GF
    Neuropharmacology; 2009; 56 Suppl 1(Suppl 1):18-31. PubMed ID: 18725236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism.
    Valdez GR; Koob GF
    Pharmacol Biochem Behav; 2004 Dec; 79(4):671-89. PubMed ID: 15582675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence.
    Smith RJ; Aston-Jones G
    Brain Struct Funct; 2008 Sep; 213(1-2):43-61. PubMed ID: 18651175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increases of CRF in the amygdala are responsible for reinstatement of methamphetamine-seeking behavior induced by footshock.
    Nawata Y; Kitaichi K; Yamamoto T
    Pharmacol Biochem Behav; 2012 Apr; 101(2):297-302. PubMed ID: 22252103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress, corticotropin-releasing factor, and drug addiction.
    Koob GF
    Ann N Y Acad Sci; 1999; 897():27-45. PubMed ID: 10676433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of adolescent alcohol exposure on stress-induced reward deficits, brain CRF, monoamines and glutamate in adult rats.
    Boutros N; Der-Avakian A; Kesby JP; Lee S; Markou A; Semenova S
    Psychopharmacology (Berl); 2018 Mar; 235(3):737-747. PubMed ID: 29181815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.